Chlorpheniramine

Back to search

Molecule Structure

Scientific Name

Chlorpheniramine

Description of the Drug

Chlorpheniramine is a histamine-H1 receptor antagonist indicated for the management of symptoms associated with upper respiratory allergies.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01114

Brand Name(s)

Not Available

Company Owner(s)

Lannett Co Inc, Watson Laboratories Inc, Impax Laboratories Inc, Mayne Pharma Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Schering Corp Sub Schering Plough Corp, Alza Corp, Private Formulations Inc, Dm Graham Laboratories Inc, Newtron Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Histamine H1 receptor SINGLE PROTEIN ANTAGONIST CHEMBL231

Unichem Links

Atlas chlorpheniramine
SureChEMBL SCHEMBL4219
PharmGKB PA448960
Human Metabolome Database HMDB0001944
WDI CLPHENTAN CLPHENAMN
DrugBank DB01114
PubChem: Thomson Pharma 14775101
PubChem 2725
Mcule MCULE-2363896855
LINCS LSM-1263
Nikkaji J441.686D J19.804H J5.570K J64.094H
EPA CompTox Dashboard DTXSID0022804
DrugCentral 616
Guide to Pharmacology 6976
GSRS 7c197b6e-e419-460a-89b7-8cc1068639ae
rxnorm CHLORPHENIRAMINE CHLOR-TRIMETON CHLORPHENIRAMINE POLISTIREX CHLORPHENIRAMINE MALEATE
KEGG Ligand C06905
ChEBI 52010